Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: Correlation between plasma neurohormones and right ventricular dysfunction

Heart

Volumn 86, Issue 1, 2001, Pages 27-30

  Tulevski, I I ^a   Groenink, M ^a   Van Der Wall, E E ^b   Van Veldhuisen, D J ^c   Boomsma, F ^d   Stoker, J ^a   Hirsch, A ^a   Lemkes, J S ^a   Mulder, B J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Congenital heart disease; Natriuretic peptides; Pressure overload; Right ventricle

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; ELECTROCARDIOGRAM; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE FUNCTION; HEART VENTRICLE OVERLOAD; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 0034768332     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.86.1.27     Document Type: Article

References (19)

1. Ventricular performance in congenital heart disease
2. The difficulties of assessing right ventricular function
3. Can indices of left ventricular function be applied to the right ventricle?
4. Biochemical detection of left-ventricular systolic dysfunction
5. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
6. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
7. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
8. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure
9. High-versus low-dose ACE inhibition in chronic heart failure: A double-blind, placebo-controlled study of imidapril
10. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension
11. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia
12. Evaluation of cardiac function with magnetic resonance imaging
13. Magnetic resonance measurement of velocity and flow: Technique, validation, and cardiovascular applications
14. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation
15. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction
16. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population
17. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction - Comparison with plasma angiotensin II and endothelin-1
18. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
19. Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure